VNDA

VANDA PHARMACEUTICALS INC

Healthcare | Small Cap

-$0.49

EPS Forecast

$58.01

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$0.49

Revenue Forecast:

$58.01

EPS Surprise Forecast:

$0.044

Revenue Surprise Forecast:

$1

Post-release price volatility - High

Post-release Overnight Move:

±9.1%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

66%

Probability of beating revenue consensus:

60%

Probability of beating both EPS & revs consensus:

46%

Probability of missing both EPS & revs consensus:

19%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

0

Beta (β)

Forward Looking Beta (β):

1.49

Earnings volatility

EPS standard deviation:

$0.25

Revenue standard deviation:

$9

As % of share price:

2.94% VERY HIGH

As % of market cap:

1.82% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

-$0.18

Revenue 95th %ile:

$69

EPS 75th %ile:

-$0.40

Revenue 75th %ile:

$61

EPS 25th %ile:

-$0.56

Revenue 25th %ile:

$56

EPS 5th %ile:

-$0.79

Revenue 5th %ile:

$49

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

37% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

60% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$25

Bid-ask per Share:

$0.02